Urogenital schistosomiasis is associated with signatures of microbiome dysbiosis in Nigerian adolescentsOriginal paper
Karen Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease, four years before the first published case study.
Read MoreWhat was studied?
This study examined whether infection with Schistosoma haematobium, the parasite that causes urogenital schistosomiasis, is associated with changes in the composition of the gut microbiome. The researchers compared fecal microbiome profiles between infected and uninfected individuals to test the hypothesis that this helminthic infection disrupts immune system-microbiota homeostasis. They also assessed the functional potential of the microbial communities, looking at enrichment of specific bacterial gene orthologs.
Who was studied?
The study population consisted of schoolchildren from the Argungu Local Government Area of Kebbi State, Nigeria. Participants were divided into two groups based on infection status: those infected with S. haematobium and those uninfected. Fecal samples from these schoolchildren were used to characterize and compare the two groups' gut microbiomes.
What were the most important findings?
Infected schoolchildren showed significant differences in gut microbial community composition compared to uninfected children, most notably a decreased abundance of Firmicutes and an increased abundance of Proteobacteria, a shift previously associated with dysbiosis. At the lower taxonomic level, the infected group had decreases in Clostridiales along with increases in Moraxellaceae, Veillonellaceae, Pasteurellaceae, and Desulfovibrionaceae, the family that includes sulfate-reducing, hydrogen sulfide-producing bacteria. Functional analysis further revealed enrichment of urease orthologs in the infected group, a feature that has been linked to dysbiosis and inflammation.
What are the greatest implications of this study?
These findings suggest that urogenital schistosomiasis may extend its impact beyond the urogenital vasculature to alter the gut microbiome, implicating a gut-parasite interaction with features of inflammation-associated dysbiosis. The rise in Desulfovibrionaceae points to a potential role for sulfate-reducing bacteria and hydrogen sulfide production in the dysbiotic shift seen with this infection. Because urogenital schistosomiasis is a neglected tropical disease affecting many children in endemic regions, these microbiome changes may represent an underappreciated dimension of disease burden worth further investigation.